Arthneeti

Archit Organosys Share Price & Earnings Call Analysis

₹67.91+2.86% today
Market cap
₹139 Cr
P/E
18.73
ROE
11.41%
PEG
-3.45
Price to sales
0.96
Debt to equity
0.33
52W high / low
₹70.3 / ₹36.1
Sales growth (5Y)
8.32%
EBITDA margin
10.80%
Net profit margin
5.89%
Promoter holding
65.88%
Sales (last year)
₹145 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Archit Organosys rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Archit Organosys.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Archit Organosys

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Archit Organosys

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +46.5531.0026.3924.8130.9927.0029.5425.8743.1833.2032.8638.4036.50
Expenses +43.6327.7624.2823.7130.7023.9526.6923.2138.7629.0630.1633.7231.61
Operating Profit2.923.242.111.100.293.052.852.664.424.142.704.684.89
OPM %6.27%10.45%8.00%4.43%0.94%11.30%9.65%10.28%10.24%12.47%8.22%12.19%13.40%
Other Income +1.350.710.540.524.110.470.630.931.061.001.460.90-0.47
Interest0.500.520.650.770.640.620.780.470.710.600.670.560.46
Depreciation1.171.191.491.491.481.491.501.491.461.491.521.521.49
Profit before tax2.602.240.51-0.642.281.411.201.633.313.051.973.502.47
Tax %22.69%26.79%27.45%-29.69%21.49%29.08%15.00%37.42%38.67%33.11%21.83%30.86%18.22%
Net Profit +2.011.640.37-0.461.791.011.021.012.022.041.542.432.02
EPS in Rs0.980.800.18-0.220.870.490.500.490.980.990.751.180.98

Financials of Archit Organosys

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +56514882847795138128113126141
Expenses +53484478877383121108106113125
Operating Profit2344-3411172071316
OPM %4%6%8%5%-4%5%12%12%15%6%10%12%
Other Income +110332013633
Interest111443322332
Depreciation001333455666
Profit before tax1230-6-1511154811
Tax %43%37%42%-32%-25%1%-7%28%26%24%33%27%
Net Profit +1121-5-15811358
EPS in Rs0.870.971.140.34-3.14-0.533.344.015.571.632.463.91
Dividend Payout %0%0%0%0%0%0%15%19%9%0%0%26%

Financials of Archit Organosys

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3510151515152121212121
Reserves2817252019263141444956
Borrowings +91131363733303431262825
Other Liabilities +10812261216171827182625
Total Liabilities243270101848387104120108123127
Fixed Assets +6647474750484550605450
CWIP08185131314110
Investments000000014667
Other Assets +181822463232374452426270
Total Assets243270101848387104120108123127

Financials of Archit Organosys

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +212-43811111810193
Cash from Investing Activity +-2-8-35-91-1-3-12-12-2-214
Cash from Financing Activity +1732130-9-72-7-9-1-6
Net Cash Flow0-0-004-212-0-1-41
Free Cash Flow-0-7-32-13368-0915181
CFO/OP93%57%75%-90%-97%221%99%71%108%164%150%30%

Financials of Archit Organosys

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days76798614062949772107726764
Inventory Days282827413022212216161811
Days Payable72638012655888751110629465
Cash Conversion Cycle33443356382830441326-810
Working Capital Days-131912-23-39-15-010104540
ROCE %20%17%9%6%-4%3%12%18%17%4%11%13%

Continue your research

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF